Cite
HARVARD Citation
Cosman, F. et al. (2018). FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. Journal of bone and mineral research. pp. 1219-1226. [Online].